Notification of Interim Results

RNS Number : 2827M
Futura Medical PLC
15 July 2014
 



For immediate release

15 July 2014

 

 

 

Futura Medical plc

("Futura" or the "Company")

 

Notice of Interim Results

 

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, will announce its interim results for the six months ended 30 June 2014 on Thursday 11  September 2014.

 

A briefing for analysts will be held at 10.00am on the morning of the results at the offices of Buchanan, 107 Cheapside, London EC2V 6DN.

 

There will be a webcast of the analyst presentation. If you would like to listen to the webcast, please log on to the following web address approximately 5 minutes before 10.00am on the day of results:

http://media.buchanan.uk.com/2014/futuramedical110914/registration.asp

A recording of the webcast will also be made available at www.futuramedical.com and www.buchanan.uk.com, following the results meeting.

 

For more information, or to register attendance, please contact Buchanan on 020 7466 5000.

 

For any further information please contact:

 

Futura Medical plc


James Barder, Chief Executive

Tel: +44 (0)1483 685 670

mail to: james.barder@futuramedical.com

www.futuramedical.com



N+1 Singer (Nominated Adviser and Broker)


Aubrey Powell - Corporate Finance

Brough Ransom - Sales

Tel:+44 (0) 20 7496 3000

 

 


For media enquiries please contact:


Buchanan


Mark Court / Fiona Henson / Sophie Cowles

Tel: +44 (0)20 7466 5000

 

 

Notes to Editors

 

Futura Medical plc

 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

 

www.futuramedical.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NOREAKXLFFXLEFF
UK 100

Latest directors dealings